Maryam Urooj

Maryam Urooj

Auto-generated profile, based on publicly available information

Maryam Urooj

Dow International Medical College, Dow University of Health Sciences, Karachi, Sindh, 74200, Pakistan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2023 in Future Science OA
Verified
Journal Article
Open access
AMAreeba Memon
Areeba Memon
MLMuhammad Omar Larik
Muhammad Omar Larik
ZKZoha Khan
Zoha Khan
MUMaryam Urooj
Maryam Urooj
AIAreeka Irfan
Areeka Irfan
IHIshaque Hameed
Ishaque Hameed
Aim: This meta-analysis was performed to assess the efficacy and safety of mavacamten in patients with hypertrophic cardiomyopathy. Methods & materials: A search was conducted using PubMed, Cochran... Plain language summary Mavacamten is a recently introduced medication that relaxes the heart muscle and is indicated for patients with hypertrophic cardiomyopathy (a disease in which parts of the h... Tweetable abstract The efficacy and safety of mavacamten, a novel drug, was assessed in patients of hypertrophic cardiomyopathy. It was noted that mavacamten significantly improved NYHA class, KCCQ... Graphical abstract

31 January 2024 in Future Science OA
Verified
Journal Article
Open access
FAFatima Azam
Fatima Azam
MDMuhammad Hamza Dawood
Muhammad Hamza Dawood
ARAroosa Roshan
Aroosa Roshan
MUMaryam Urooj
Maryam Urooj
ZKZoha Khan
Zoha Khan
AIAlizeh Imran
Alizeh Imran
Aim: We analyzed the 100 most-cited articles on all anti-diabetic drugs. A comprehensive literature review found no bibliometrics on this. Methods: Two researchers independently extracted articles ...